Summary
Chlordiazepoxide was the first benzodiazepine derivative made available for clinical use. The metabolic pathway of chlordiazepoxide is complex, since the drug is biolransformed into a succession of pharmacologically active products: desmethylchlordiazepoxide, demoxepam, desmethyldiazepam, and oxazepam. The elimination half-life (t1/2β) chlordiazepoxide following single doses in healthy individuals generally ranges from 5 to 30 hours, and the volume of distribution from 0.25 to 0.50 liters/kg. The hepatic extraction ratio is well under 5 %. Elimination of the parent compound is mirrored by formation of the first active metabolite.
Clearance of chlordiazepoxide is reduced and (t1/2β) is prolonged in the elderly, in those with cirrhosis, and in those receiving concurrent disulfiram therapy. Oral chlordiazepoxide is rapidly and completely absorbed, but intramuscular injection is painful and results in slow and erratic absorption. Multiple-dose therapy with chlordiazepoxide results in accumulation of the parent compound, as well as two or more of its active metabolites. The rate and extent of accumulation varies considerably between individuals.
A relation between plasma concentrations of chlordiazepoxide and its metabolites to clinical effects has been suggested in some studies and is currently under further investigation.
Similar content being viewed by others
References
Bond, A.J.; Hailey, D.M. and Lader, M.H.: Plasma concentrations of benzodiazepines. British Journal of Clinical Pharmacology 4: 51–56 (1977).
Boston Collaborative Drug Surveillance Program: Clinical depression of the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age. New England Journal of Medicine 288: 277–280 (1973).
Boxenbaum, H.G.; Geitner, K.A.; Jack, M.L.; Dixon, W.R. and Kaplan, S.A.: Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: Multiple-dose oral administration. Journal of Pharmacokinetics and Biopharmaceutics 5: 25–39 (1977b).
Boxenbaum, H.G.; Geitner, K.A.; Jack, M.L.; Dixon, W.R.; Spiegel, H.E.; Symington, J.; Christian, R.; Moore, J.D.; Weissman, L. and Kaplan, S.A.: Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: Single-dose studies by the intravenous, intramuscular, and oral routes. Journal of Pharmacokinetics and Biopharmaceutics 5: 3–23 (1977a).
Crooks, J.; O’Malley, K. and Stevenson, I.H.: Pharmacokinetics in the elderly. Clinical Pharmacokinetics 1: 280–296 (1976).
Decancq, H.G. Jr.; Bosco, J.R. and Townsend, E.H. Jr.: Chlordiazepoxide in labor. Journal of Pediatrics 67: 836–840 (1965).
deSilva, J.A.F.; Bekersky, I.; Puglisi, C.V.; Brooks, M.A. and Weinfeld, R.E.: Determination of 1,4-benzodiazepines and -diazepin-2-ones in blood by electron-capture gas-liquid chromatography. Analytical Chemistry 48: 10–19 (1976).
Dixon, R.; Brooks, M.A.; Postma, E.; Hackman, M.R.; Spector, S.; Moore, J.D. and Schwartz, M.A.: N-desmethyldiazepam: a new metabolite of chlordiazepoxide in man. Clinical Pharmacology and Therapeutics 20: 450–457 (1976).
Ferguson, J.L. and Couri, D.: Electron capture gas chromatography determination of benzodiazepines and metabolites. Journal of Analytical Toxicology 1: 171–174 (1977).
Gottschalk, L.A.; Biener, R. and Dinovo, E.C.: Effects of oral and intramuscular routes of administration on serum chlordiazepoxide levels and the prediction of these levels from predrug fasting serum glucose concentrations. Research Communications in Chemical Pathology and Pharmacology 8: 697–702 (1974).
Gottschalk, L.A. and Kaplan, S.A.: Chlordiazepoxide plasma levels and clinical responses. Comprehensive Psychiatry 13: 519–527 (1972).
Greenblatt, D.J.; Harmatz, J.S.; Stanski, D.R.; Shader, R.I.; Franke, K. and Koch-Weser, J.: Factors influencing blood concentrations of chlordiazepoxide: A use of multiple regression analysis. Psychopharmacology 54: 277–282 (1977c).
Greenblatt, D.J. and Koch-Weser, J.: Clinical pharmacokinetics. New England Journal of Medicine 293: 702–705, 964-970 (1975).
Greenblatt, D.J. and Shader, R.I.: Benzodiazepines in Clinical Practice (Raven Press, New York 1974).
Greenblatt, D.J.; Shader, R.I.; Franke, K. and Harmatz, J.S.: Pharmacokinetics of chlordiazepoxide and metabolites following single and multiple oral doses. International Journal of Clinical Pharmacology and Biopharmacy. In press (1978b).
Greenblatt, D.J.; Shader, R.I.; Franke, K.; MacLaughlin, D.S.; Ransil, B.J. and Kock-Weser, J.: Kinetics of intravenous chlordiazepoxide: sex differences in drug distribution. Clinical Pharmacology and Therapeutics 22: 893–903 (1977a).
Greenblatt, D.J.; Shader, R.I.; Harmatz, J.S.; Franke, K. and Koch-Weser, J.: Influence of magnesium and aluminium hydroxide mixture on chlordiazepoxide absorption. Clinical Pharmacology and Therapeutics 19: 234–239 (1976b).
Greenblatt, D.J.; Shader, R.I.; Harmatz, J.S.; Franke, K. and Koch-Weser, J.: Absorption rate, blood concentrations, and early response to oral chlordiazepoxide. American Journal of Psychiatry 134: 559–562 (1977b).
Greenblatt, D.J.; Shader, R.I. and Koch-Weser, J.: Pharmacokinetic determinants of the response to single doses of chlordiazepoxide. American Journal of Psychiatry 131: 1395–1397 (1974b).
Greenblatt, D.J.; Shader, R.I. and Koch-Weser, J.: Serum creatine Phosphokinase concentrations after intramuscular chlordiazepoxide and its solvent. Journal of Clinical Pharmacology 16: 118–121 (1976a).
Greenblatt, D.J.; Shader, R.I.; Koch-Weser, J. and Franke, K.: Slow absorption of intramuscular chlordiazepoxide. New England Journal of Medicine 291: 1116–1118 (1974a).
Greenblatt, D.J.; Shader, R.I.; MacLeod, S.M.; Sellers, E.M.; Franke, K. and Giles, H.G.: Absorption of oral and intramuscular chlordiazepoxide. European Journal of Clinical Pharmacology. In press (1978a).
Greizerstein, H.B. and Wojtowicz, C.: Simultaneous determination of chlordiazepoxide and its N-demethyl metabolite in 50-Mu-L blood samples by high pressure liquid chromatography. Analytical Chemistry 49: 2235–2236 (1977).
Hackman, M.R.; Brooks, M.A. and deSilva, J.A.F.: Determination of chlordiazepoxide hydrochloride (Librium) and its major metabolites in plasma by differential pulse polarography. Analytical Chemistry 46: 1075–1082 (1974).
Koechlin, B.A. and D’Arconte, L.: Determination of chlordiazepoxide (Librium) and of a metabolite of lactam character in plasma of humans, dogs, and rats by a specific spectrofluorometric micro method. Analytical Biochemistry 5: 195–207 (1963).
Koechlin, B.A.; Schwartz, M.A.; Krol, G. and Oberhansli, W.: The metabolic fate of C14-labeled chlordiazepoxide in man, in the dog, and in the rat. Journal of Pharmacology and Experimental Therapeutics 148: 399–411 (1965)
Lin, K.-M. and Friedel, R.O.: Relationship of plasma levels of chlordiazepoxide and metabolites to clinical response. American Journal of Psychiatry. In press (1978).
Linnoila, M.; Otterstrom, S. and Anttila, M.: Serum chlordiazepoxide, diazepam and thioridazine concentrations after the simultaneous ingestion of alcohol or placebo drink. Annals of Clinical Research 6: 4–6 (1974).
MacDonald, A.; Michaelis, A.F. and Senkowski, B.Z.: Chlordiazepoxide; in Florey (Ed) Analytical Profiles of Drug Substances, Vol. 1, p. 15–37 (Academic Press, New York, 1972b).
MacDonald, A.; Michaelis, A.F. and Senkowski, B.Z.: Chlordiazepoxide hydrochloride; in Florey (Ed) Analytical Profiles of Drug Substances, Vol. 1, p. 39–51 (Academic Press, New York, 1972a).
MacLeod, S.M.; Greenblatt, D.J. and Sellers, E.M.: Determination of intravenous chlordiazepoxide (CDX) pharmacokinetics: plasma versus blood. Clinical Research 25: 273A (1977).
Randall, L.O. and Kappell, B.: Pharmacological activity of some benzodiazepines and their metabolites; in Garattini, Mussini and Randall (Eds) The Benzodiazepines, p. 27–51 (Raven Press, New York, 1973).
Randall, L.O.; Schallek, W.; Heise, G.A.; Keith, E.F. and Bagdon, R.E.: The psychosedative properties of methaminodiazepoxide. Journal of Pharmacology and Experimental Therapeutics 129: 163–171 (1960).
Roberts, R.K.; Wilkinson, G.R.; Branch, R.A. and Schenker, S.: Effect of age and cirrhosis on the disposition and elimination of chlordiazepoxide (Librium). Gastroenterology 73: A45/1243 (1977).
Sadee, W. and van der Kleijn, E.: Thermolysis of 1,4-benzodiazepines during gas chromatography and mass spectroscopy. Journal of Pharmaceutical Sciences 60: 135–137 (1971).
Schwartz, M.A. and Postma, E.: Metabolic N-demethylation of chlordiazepoxide. Journal of Pharmaceutical Sciences 55: 1358–1362 (1966).
Schwartz, M.A. and Postma, E.: Metabolites of demoxepam, a chlordiazepoxide metabolite, in man. Journal of Pharmaceutical Sciences 61: 123–125 (1972).
Schwartz, M.A.; Postma, E. and Gaut, Z.: Biological half-life of chlordiazepoxide and its metabolite, demoxepam, in man. Journal of Pharmaceutical Sciences 60: 1500–1503 (1971).
Sellers, E.M.; MacLeod, S.M. and Greenblatt, D.J.: Unpublished data (1978).
Sellers, E.M.; MacLeod, S.M.; Greenblatt, D.J. and Giles, H.G.: Inhibition of chlordiazepoxide biotransformation by disulfiram. Clinical Research 24: 652A (1976).
Sellers, E.M.; MacLeod, S.M.; Greenblatt, D.J. and Giles, H.G.: Influence of disulfiram and disease on benzodiazepine disposition. Clinical Pharmacology and Therapeutics 21: 117 (1977).
Shader, R.I.; Greenblatt, D.J.; Harmatz, J.S.; Franke, K. and Koch-Weser, J.: Absorption and disposition of chlordiazepoxide in young and elderly male volunteers. Journal of Clinical Pharmacology 17: 709–718 (1977).
Smith, T.C. and Moyer, C.E.: Bioavailability of two preparations of chlordiazepoxide. Current Therapeutic Research 20: 204–210 (1976).
Stanski, D.R.; Greenblatt, D.J., Selwyn, A.; Shader, R.I.; Franke, K. and Koch-Weser, J.: Plasma and cerebrospinal fluid concentrations of chlordiazepoxide and its metabolites in surgical patients. Clinical Pharmacology and Therapeutics 20: 571–578 (1976).
Sternbach, L.H.; Koechlin, B.A. and Reeder, E.; Quinazolines and 1,4-benzodiazepines. (VIII). The photoisomerization of 7-chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine 4-oxide. Journal of Organic Chemistry 27: 4671–4672 (1962).
Stewart, J.T. and Williamson, J.L.: Fluorometric determination of chlordiazepoxide in dosage forms and biological fluids with fluorescamine. Analytical Chemistry 48: 1182–1185 (1976).
Strojny, N.; Bratin, K.; Brooks, M.A. and deSilva, J.A.F.: Determination of chlordiazepoxide, diazepam, and their major metabolites in blood or plasma by spectrophotodensitometry. Journal of Chromatography 143: 363–374 (1977).
Zingales, I.A.: Determination of chlordiazepoxide plasma concentrations by electron capture gas-liquid chromatography. Journal of Chromatography 61: 237–252 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Greenblatt, D.J., Shader, R.I., MacLeod, S.M. et al. Clinical Pharmacokinetics of Chlordiazepoxide. Clin Pharmacokinet 3, 381–394 (1978). https://doi.org/10.2165/00003088-197803050-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-197803050-00004